Major histocompatibility complex class I-restricted infiltration and destruction of pancreatic islets by NOD mouse-derived β-cell cytotoxic CD8+ T-cell clones in vivo

Diabetes

Volumn 45, Issue 8, 1996, Pages 1121-1131

  Utsugi, Toshihiro ^a   Yoon, Ji Won ^a   Park, Byung Ju ^a   Imamura, Minoru ^a   Averill, Nuzhat ^a   Kawazu, Shoji ^b   Santamaria, Pere ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; STREPTOZOCIN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CLONE; CELL INFILTRATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HISTOPATHOLOGY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; REVASCULARIZATION;

EID: 0029783716     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.45.8.1121     Document Type: Article

References (36)

1. Serreze DA, Leiter EH: Genetic and pathogenic basis of autoimmune diabetes in NOD mice. Curr Opin Immunol 6:900-906, 1994
2. Bendelac A, Carnaud C, Boitard C, Bach J-F: Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates: requirement for both L3T4+ and Lyt-2+ T-cells. J Exp Med 166:823-832, 1987
3. Miller BJ, Appel MC, O'Neil JJ, Wicker LS: Both the Lyt-2+ and L3T4+ T cell subsets are required for the transfer of diabetes in non-obese diabetic mice. J Immunol 140:52-58, 1988
4. Yagi H, Matsumoto M, Kunimoto K, Kawaguchi J. Makino S, Harada M: Analysis of the roles of CD4+ and CD8+ T-cells in autoimmune diabetes of NOD mice using transfer to NOD athymic nude mice. Eur J Immunol 22:2387-2393, 1992
5. Matsumoto M, Yagi H, Kunimoto K, Kawaguch J, Makino S, Harada M: Transfer of autoimmune diabetes from diabetic NOD mice to NOD athymic nude mice: the roles of T cell subsets in the pathogenesis. Cell Immunol 148:189-197, 1993
6. Christianson SW, Shultz LD, Leiter EH: Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice: relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-thy-1a donors. Diabetes 42:44-55, 1993
7. Haskins K, McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 249:1433-1436, 1990
8. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
9. Bradley BJ, Haskins K, LaRosa FG, Lafferty K: CD8+ T-cells are not required for islet destruction induced by a CD4+ islet-specific T-cell clone. Diabetes 41:1603-1608, 1992
10. Peterson JD, Pike B, McDuffie M, Haskins KJ: Islet-specific T cell clones transfer diabetes to nonobese diabetic (NOD) F1 mice. J Immunol 153:2800-2807, 1994
11. Reich EP, Sherwin RS, Kanagawa O, Janeway CA Jr: An explanation for the protective effect of the MHC class III-E molecule in murine diabetes. Nature 341:326-328, 1989
12. Santamaria P, Utsugi T, Park BJ, Averill N, Kawazu S, Yoon J-W: Beta cell-cytotoxic CD8+ T cells from non obese diabetic mice use highly homologous T cell receptor-α chain CDR3 sequences. J Immunol 154:2494-2503, 1995
13. Nagata M, Santamaria P, Kawamura T, Utsugi T, Yoon J-W: Evidence for the role of CD8+ cytotoxic T-cells in the destruction of pancreatic beta cells in NOD mice. J Immunol 152:2042-2050, 1994
14. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for meassuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Meth 95:99-106, 1986
15. Utsugi T, Nagata M, Kawamura T, Yoon J-W: Prevention of recurrent diabetes in syngenic islet-transplanted NOD mice by transfusion of autoreactive T lymphocytes. Transplantation 57:1799-1804, 1994
16. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP: An improved method for isolation of mouse pancreatic islets. Transplantation 40:437-438, 1985
17. Weston SA, Parish CB: New fluorescent dyes for lymphocyte migration studies: analysis by flow cytometry and fluorescence microscopy. J Immunol Meth 133:87-97, 1990
18. Shizuru JA, Taylor-Edwards C, Banks BA, Gregory AK, Fathman GC: Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240:659-662, 1988
19. Menger MD, Vajkoczy P, Leiderer R, Jäger S, Messmer K: Influence of experimental hyperglycemia on microvascular blood perfusion of pancreatic islet isografts. J Clin Invest 90:1361-1370, 1992
20. Menger MD, Vajkoczy P, Beger C, Messmer K: Orientation of microvascular blood flow in pancreatic islet isografts. J Clin Invest 93:2280-2288, 1994
21. Lee M-S, Sarvetnick N: Induction of vascular addressins and adhesion molecules in the pancreas of IFN-γ transgenic mice. J Immunol 152:4597-4603, 1994
22. Higuchi Y, Herrera P, Muniesa P, Huarte J, Belin D, Ohashi P, Aichele P, Orci L, Vassalli JD: Expression of a tumor necrosis factor-α transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J Exp Med 176:1719-1727, 1992
23. Picarella DE, Kratz A, Li CB, Ruddle NH, Flavell RA: Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes: distinct patterns of inflammation in TNF-α and TNF-β transgenic mice. J Immunol 150:4136-4144, 1992
24. Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH: Affinity-purified human interleukin-1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29:63-67, 1986
25. Mandrup-Ponlsen T, Bendtzen K, Dinarello C, Nerup J: Human tumornecrosis factor potentiates human interleukin 1-mediated rat panereatic beta cell-cytotoxicity. J Immunol 139:4077-4084, 1987
26. Pukel C, Baquerizo H, Rabinovitch A: Destruction of rat islet cell monolayers by cytokines: synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin and interleukin-1. Diabetes 37:133-140, 1988
27. Campbell IL, Iscaro A, Harrison LC: IFN-γ and tumor necrosis factor-α cytotoxicity to murine islets of Langerhans. J Immunol 141:2325-2333, 1988
28. Picker LJ: Control of lymphocyte homing. Curr Opin Immunol 6:394-406, 1994
29. Berlin C, Bargatze RF, Campbell JJ, von Adrian UH, Szabo MC, Hasslen SR, Nelson RD, Berg EL, Erlandsen SL, Butcher EC: α4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422, 1995
30. Yang X-D, Karin N, Tisch R, Steinman L, McDevitt HO: Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA 90:10494-10498, 1993
31. Hanninen A, Taylor C, Streeter PR, Stark LS, Sarte JM, Shizuru JA, Simell O, Michie SA: Vascular addressins are induced on islet vessels during insulitis in nonobese diabetic mice and are involved in lymphoid cell binding to islet endothelium. J Clin Infest 92:2590-2597, 1993
32. Faveeuw C, Gagnerault M-C, Lepault F: Expression of homing and adhesion molecules in infiltrated islets of Langerhans and salivary glands of nonobese diabolic mice. J Immunol 152:5989-5978, 1994
33. Mann R, Zakheim B, dayman EM, McCafferty E, Michaud L, Neilson EG: Murine interstitial nephritis. IV. Long term cultured L3T4+ T cell lines transfer delayed expression of disease as I-A-restricted inducers of the effector T cell repertoire. J Immunol 135:286-295, 1985
34. Ando K, Guidotti LG, Cerny A, Ishikawa T, Chisari FV: CTL access to tissue antigen is restricted in vivo. J Immunol 153:482-488, 1994
35. Ando K, Guidotti LG, Wirth S, Ishikawa T, Missale G, Moriyama T, Schreiber RD, Schlicht HJ, Huang SN, Chisari FV: Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their targe T-cells in vivo. J Immunol 152:3245-3253, 1994
36. Bradley BJ, Wang YY, Lafferty KJ, Haskins K: In viva activity of an islet-reactive T-cell clone. J Autoimmun 3:449-456, 1990